HOME >> BIOLOGY >> NEWS
Biotech Creates New Solutions And New Problems

Since recombinant DNA techniques were first developed by University of California, San Francisco, and Stanford University scientists in 1973, biotechnology has found commercial application in medicine, food processing and, more recently, agriculture. This year U.S. growers planted 45 million acres of transgenic crops, including herbicide-tolerant, insect- and disease-resistant varieties. But while transgenic crops offer new options for California farmers, they raise questions as well. This issue of California Agriculture explores two of them: how privatization of proprietary rights to key biotechnology will affect public germplasm development, and how the problems of pest resistance may affect the long-term success of larvae-killing transgenic cotton.

Genetic materials ranging from DNA sequences to whole plants, as well as essential biotechnology tools and techniques, are being patented by private and public research entities. At the same time, a series of mergers and acquisitions in the agrochemical and seed industries has led to increasing dominance by a small number of corporations in these fields. Such industrywide changes signal a profound shift in the ownership of life forms and the recombinant DNA tools needed to manipulate them. These changes present problems both for growers of major crops, who find they have an increasingly limited number of suppliers, and growers of minor crops, who may find that transgenic research useful to them is never developed because the potential market is too small.

Plants genetically engineered to produce insecticidal proteins of the bacterium Bacillus thuringiensis provide effective, environmentally safe pest control. However, current transgenic crops have in some cases encountered insect resistance, partly because they have been engineered to produce only a single type of Bt insecticidal protein, and partly because as crop plants age they may produce lower amounts of the Bt protein.


'"/>

Contact: Pam Kan-Rice
pamela.kan-rice@ucop.edu
510-987-0043
University of California - Division of Agriculture & Natural Resources
22-Dec-1998


Page: 1 2 3

Related biology news :

1. Nanosphere announces genetic detection advance in Nature Biotechnology
2. Leroy Hood to receive 2004 Biotechnology Heritage Award
3. Christopher Walsh wins 2004 Promega Biotechnology Research Award
4. Advancing Biotechnology Breakthroughs
5. Bacteriophage genomics approach to antimicrobial drug discovery published in Nature Biotechnology
6. Quark Biotech generates a cholesterol-free mouse
7. Army awards up to $50 million to establish Institute for Collaborative Biotechnologies
8. US-EC Biotech Task Force keys on research, collaboration
9. Chemical Heritage Foundation and BIO give Biotechnology Heritage Award to William Rutter
10. Biotechnology taught as a tool for teaching
11. Biotech regulations impede crop domestication

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Biotech Creates New Solutions And New Problems

(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of insulin ... other mental capabilities in adults with mild cognitive impairment ... led by researchers at Wake Forest Baptist Medical Center. ... with amnesic mild cognitive impairment (MCI) or mild to ...
(Date:1/22/2015)... 2015 , Europe,s ... The European Patent Office to present a video retrospective of the ... be featured: Christofer Toumazou and Sophie Wilson   ... winners of the Award   Starting on 22 January ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 2Ten Years of the European Inventor Award: A Retrospective Look at the Inventors and Ideas That Have Changed Our Lives 3
(Date:1/22/2015)... Jan. 22, 2015   GenoSpace , a precision medicine software ... enable the broad use of genomic, imaging and other biomedical ... of Michelle Munson , CEO of Aspera, an IBM ... Logo - http://photos.prnewswire.com/prnh/20150122/170713 "We are ...
(Date:12/24/2014)... SPRING, Md. , Dec. 24, 2014  United Therapeutics ... Medtronic, Inc. (NYSE: MDT ) has submitted ... Drug Administration (FDA) for the use of Medtronic,s SynchroMed ... newly developed catheter) for use with United Therapeutics, Remodulin ...
(Date:12/24/2014)... , Dec. 24, 2014   BioLife Solutions , Inc. ... marketer of proprietary clinical grade hypothermic storage and ... products for cells and tissues  ("BioLife" or the "Company"), ... of Stockholders on May 4, 2015 (the "Annual Meeting"). ...
(Date:12/24/2014)... Earlier this year in a June 24 international conference presentation, ... Technology Center, LLC ( ASCTC ) focused attention on an ... stem cells. His title “Asymmetric Self-Renewal by Distributed Stem ... the essence of his message to congress participants. He ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
Cached News: